Structural integrity versus radiographic progression in rheumatoid arthritis

Area of Science:

• Rheumatology
• Immunology
• Pathophysiology

Background:

• Rheumatoid arthritis (RA) is a chronic inflammatory disease causing joint destruction and disability.
• RA pathogenesis involves immune tolerance breakdown, autoantibodies, and inflammation, leading to bone erosion and joint space narrowing.
• While disease-modifying antirheumatic drugs (DMARDs) slow damage, radiographic progression can persist even in clinical remission.

Purpose of the Study:

• To review the relationship between autoimmunity, inflammation, joint damage, and disability in RA.
• To explore the disconnect between clinical synovitis and radiographic progression in RA patients.
• To discuss the predictive value of radiographic progression for functional disability.

Main Methods:

• Literature review of clinical trials and pathogenetic mechanisms in RA.
• Analysis of the role of pro-inflammatory cytokines and autoantibodies (e.g., anticitrullinated protein antibodies, ACPAs) in RA.
• Discussion of the effectiveness of synthetic and biologic DMARDs and the treat-to-target strategy.

Main Results:

• RA involves complex pathways leading to bone and cartilage damage, mediated by pro-inflammatory cytokines.
• Radiographic progression can occur despite clinical remission due to limitations in remission assessment and direct effects of biologics on inflammation.
• Imaging tools may be necessary to detect residual disease activity not captured by composite indices.

Conclusions:

• The interplay between autoimmunity, inflammation, and joint damage significantly impacts functional disability in RA.
• Understanding the mechanisms driving radiographic progression, even in remission, is crucial for optimizing RA management.
• Radiographic progression serves as a critical predictor of future functional limitations in rheumatoid arthritis patients.